NovaBay Pharmaceuticals Inc (NYSE:NBY) shares are lower by 66% to $0.67 over the trailing five sessions after announcing the pricing of its public offering of 3.2 million shares (or pre-funded warrants) and Series F-1, F-2, and F-3 warrants. Each share (or pre-funded warrant) and associated warrants are priced at $1.10. The Series F-1 warrants expire in five years, the F-2 in six months and the F-3 in one year, all with a $1.10 exercise price. Ladenburg Thalmann & Co. Inc., the underwriter, has a 45-day option to purchase an additional 477,272 shares and/or warrants for over-allotments. Expect…